these data imply that human peripheral blood mononuclear cells retain fully their capacity for ril-2-induced activation and effector cell function under this alternative approach , and further , that a low-dose ril-2 regimen with markedly reduced toxicities can be as effective as high-dose ril-2 regimens if low-dose ril-2 is given for a prolonged period of time following lak cell infusion .
C0086418
human
C1335621
ril